This Houston innovator is using data to power industrial reliability and sustainability

HOUSTON INNOVATORS PODCAST EPISODE 92

Ryan Sitton joins the Houston Innovators Podcast to discuss his career in data and reliability. Photo courtesy of Ryan Sitton

Ryan Sitton has had a varied career so far. Formerly working in oil and gas, he started his own company in 2006 to help companies to better utilize their data. Now, still leading Houston-based Pinnacle as CEO, Sitton works with the world's largest companies to solve their problems with data. He also served as Texas Railroad Commissioner and has written two books about decision-making and leadership.

Sitton joined the Houston Innovators Podcast to discuss how, despite the multiple hats he wears, at the core of his passion is using data to drive better decision making to drive more sustainable and reliable operations.

"I was basically doing data analytics in the mid 2000s before it was sexy. I was pulling together data in chemical plants and refineries and trying to predict how these plants would behave with the data I had," Sitton says. "I realized early on how there was so much opportunity here — but we don't have the technologies or the methodology to do it."

But over the years, the technology has caught up and now Sitton is able to provide clients with even more data-driven solutions.

"We go into the biggest companies of the world that are trying to have more reliability at the same time as lowering cost," Sitton explains. "We build models that pull together literally millions of pieces of data and we do a combination of engineering analysis and data analysis and data science to give them better predictions — better ways to run their facilities so that they are more sustainable and more profitable."

Sitton's two books — Crucial Decisions, which is out now, and the Myth of Status, which is coming later this year — also center around decision making and leadership.

He shares more about his time at the Texas Railroad Commision and shares how COVID-19 affected business — as well as shares his advice for startups tapping into data-driven solutions — on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ryan Sitton's new book, "Crucial Decisions," touches on an array of topics and how data is the key to making the positive and impactful decisions. Photo via Getty Images

Houston energy expert on how big data yields more reliable results

Guest column

Abraham Maslow's hierarchy of need tells us that at our core, humans crave safety and sustenance. When you turn on the light each morning while getting ready for work, or when you check your bank account and see your paycheck arrived on schedule, we expect every aspect of our daily lives to work.

In today's world, we often take these things for granted, until reliability is threatened. Our dependency is revealed in the frenzy over a potential toilet paper shortage and in the panic buying of gasoline in a hurricane. When things in society are consistent, economies thrive. However, when you introduce fear and uncertainty, things begin to spiral. It is in these times that the decisions we make can have the biggest impact on the world around us.

The link between impactful decisions and reliability has brought our society to a pivotal moment in history. We have created a society so reliable and developed that even during the coronavirus lockdown, the basic needs of Americans could be met with only 25 percent of our workforce actively working. By increasing productivity using machines and systems, we have been able to improve our overall quality of life, but not without a price. As a result of such high improvement, we as a society have come to not only expect, but demand, reliability at all times.

When dependability waivers and anxiety rises, those in key decision-making positions are faced with unprecedented situations. Due to distress and a lack of understanding of certain situations, those in decision making positions are often times forced to make decisions based on rapid response and emotion. Because of this, consistency and reliability suffer.

A prime example of an emotional response is the coronavirus shutdown that occurred earlier this year. As a response to the growing fear and panic over the virus, major portions of our economy were shut down; schools were closed; and citizens were confined to their homes.

What followed was the bankruptcy of thousands of businesses, an unprecedented wave of fear throughout society and a disruption to the consistency of our daily lives. We have yet to know what lasting impacts this decision will have on our future economy or livelihood, but we now understand that rapid decision making is often met with long-term consequences.

While there will continue to be disagreements on all sides regarding the handling of the shutdown, what is undisputable is that we as a society have gained an opportunity to learn. We now have the unique advantage of using data in ways that has never been used before in order to make consistently better decisions, allowing us the opportunity to perform at levels we have never thought possible.

Whether it be data advancements in sports (think Billy Beane and the Oakland Athletics), or the progression of technology (continuous iPhone updates), we are able to study the improvements of data on society in order to make more reliable decisions. With more powerful data analytics and innovations in data sciences, we are able to positively impact the most vital components of our society in order to make decisions that will drive evolution and reliability.

As the world continues to progress, the decisions we are forced to make have become more complex. With each complicated decision comes the potential for lasting positive or negative impact on society. In shifting from emotional, rapid reactions towards more data and quantitative focused methods, we have the unique and unprecedented opportunity to make our world a more reliable, stable and creative place.

------

Ryan Sitton is the founder of Pinnacle and the author of "Crucial Decisions."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings